194
Views
1
CrossRef citations to date
0
Altmetric
Review

Alginate-based matrix tablets for drug delivery

ORCID Icon, &
Pages 115-130 | Received 26 Jul 2022, Accepted 09 Dec 2022, Published online: 18 Dec 2022

References

  • Donati I, Paoletti S. Material properties of alginates. In: editor, Rehm B. Alginates: biology and applications. Microbiology monographs. Vol. 13. Berlin: Springer; 2009. p. 1–55 .
  • Hasnain MS, Jameel E, Mohanta B. Alginates: sources, structure, and properties. In: Nayak AK, Hasnain MS. (editors.) Alginates in drug delivery. United Kingdom: Academic Press;2020. p.1–17
  • Fu S, Buckner IS, Block LH. Inter-grade and inter-batch variability of sodium alginate used in alginate-based matrix tablets. AAPS PharmSciTech. 2014;15(5):1228–1237.
  • Andriamanantoanina H, Rinaudo M. Relationship between the molecular structure of alginates and their gelation in acidic conditions. Polym Int. 2010;59(11):1531–1541.
  • Qin Y, Jiang J, Zhao L, et al. Applications of alginate as a functional food ingredient. In: Grumezescu AM, Holban AM, editors Biopolymers for food design. Handbook of food bioengineering. Vol. 20. United Kingdom: Academic Press; 2018. p. 409–429.
  • Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012 Jan;37(1):106–126.
  • Puscaselu RG, Lobiuc A, Dimian M, et al. Alginate: from food industry to biomedical applications and management of metabolic disorders. Polymers. 2020;12(10):2417.
  • Hariyadi DM, Islam N. Current status of alginate in drug delivery. 2020;Adv Pharmacol Pharm Sci. 2020:8886095.
  • Jain D, Bar-Shalom D. Alginate drug delivery systems: application in context of pharmaceutical and biomedical research. Drug Dev Ind Pharm. 2014;40(12):1576–1584.
  • Ahmad Z, Khuller GK. Alginate-based sustained release drug delivery systems for tuberculosis. Expert Opin Drug Deliv. 2008;5(12):1323–1334.
  • Suhail M, Khan A, Rosenholm JM, et al. Fabrication and characterization of diclofenac sodium loaded hydrogels of sodium alginate as sustained release carrier. Gels. 2021;7(1):10.
  • Khalid I, Ahmad M, Usman Minhas M, et al. Cross-linked sodium alginate-g-poly(acrylic acid) structure: a potential hydrogel network for controlled delivery of loxoprofen sodium. Adv Polym Technol. 2018;37(4):985–995.
  • Wong TW, Chan LW, Kho SB, et al. Design of controlled-release solid dosage forms of alginate and chitosan using microwave. J Control Release. 2002;84(3):99–114.
  • Sarmento B, Ferreira D, Veiga F, et al. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym. 2006;66(1):1–7.
  • Kestur U, Desai D. Excipients for conventional oral dosage forms. In: Koo OMY, editor. Pharmaceutical excipients. USA: John Wiley & Sons, Inc.; 2017. p. 51–95.
  • Berardi A, Bauhuber S, Sawafta O, et al. Alginates as tablet disintegrants: understanding disintegration mechanisms and defining ranges of applications. Int J Pharm. 2021;601:120512.
  • Gissinger D, Stamm A. A comparative evaluation of the properties of some tablet disintegrants. Drug Dev Ind Pharm. 1980;6(5):511–536.
  • Benabbas R, Sanchez-Ballester NM, Bataille B, et al. Structure-properties relationship in the evaluation of alginic acid functionality for tableting. AAPS PharmSciTech. 2020;21(3):94.
  • Wan LSC, Heng PWS. Influence of surfactant on the properties of granules and tablets containing sodium calcium alginate. Pharm Acta Helv. 1987;62(5–6):169–174.
  • Soulairol I, Sanchez-Ballester NM, Aubert A, et al. Evaluation of the super disintegrant functionalities of alginic acid and calcium alginate for the design of orodispersible mini tablets. Carbohydr Polym. 2018;197:576–585.
  • Benabbas R, Sanchez-Ballester NM, Bataille B, et al. Development and pharmaceutical performance of a novel co-processed excipient of alginic acid and microcrystalline cellulose. Powder Technol. 2021;378:576–584.
  • Bhatia V, Dhingra A, Chopra B, et al. Co-processed excipients: recent advances and future perspective. J Drug Deliv Sci Technol. 2022;71:103316.
  • Parmar PK, Rao SG, Bansal AK. Co-processing of small molecule excipients with polymers to improve functionality. Expert Opin Drug Deliv. 2021;18(7):907–928.
  • Saha S, Shahiwala AF. Multifunctional coprocessed excipients for improved tabletting performance. Expert Opin Drug Deliv. 2009;6(2):197–208.
  • Badawy SI, Gray DB, Hussain MA. A study on the effect of wet granulation on microcrystalline cellulose particle structure and performance. Pharm Res. 2006;23(3):634–640.
  • Shi L, Feng Y, Sun CC. Origin of profound changes in powder properties during wetting and nucleation stages of high-shear wet granulation of microcrystalline cellulose. Powder Technol. 2011;208(3):663–668.
  • Nokhodchi A, Raja S, Patel P, et al. The role of oral controlled release matrix tablets in drug delivery systems. BioImpacts. 2012;2(4):175–187.
  • Boyapally H, Nukala RK, Bhujbal P, et al. Controlled release from directly compressible theophylline buccal tablets. Colloids Surf B. 2010;77(2):227–233.
  • Sriamornsak P, Thirawong N, Korkerd K. Swelling, erosion and release behavior of alginate-based matrix tablets. Eur J Pharm Biopharm. 2007;66(3):435–450.
  • Malakar J, Nayak AK, Goswami S. Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release. ISRN Pharm. 2012;2012:730624.
  • Gennari CGM, Sperandeo P, Polissi A, et al. Lysozyme mucoadhesive tablets obtained by freeze-drying. J Pharm Sci. 2019;108(11):3667–3674.
  • Zhang T, Mao S, Sun W. Design and in vitro evaluation of a film-controlled dosage form self-converted from monolithic tablet in gastrointestinal environment. J Pharm Sci. 2010;99(11):4678–4690.
  • Li L, Wang L, Shao Y, et al. Drug release characteristics from chitosan-alginate matrix tablets based on the theory of self-assembled film. Int J Pharm. 2013;450(1–2):197–207.
  • Al-Zoubi NM, AlKhatib HS, Obeidat WM. Evaluation of hydrophilic matrix tablets based on Carbopol((R)) 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Drug Dev Ind Pharm. 2011;37(7):798–808.
  • Holte O, Onsoyen E, Myrvold R, et al. Sustained release of water-soluble drug from directly compressed alginate tablets. Eur J Pharm Sci. 2003;20(4–5):403–407.
  • Manuel TA, Leopoldo VR. Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets. Drug Dev Ind Pharm. 2004;30(8):901–908.
  • Abdelkader H, Abdalla OY, Salem H. Formulation of controlled release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation. AAPS PharmSciTech. 2007;8(4):1–11.
  • Gaikwad SS, Avhad RD, Kalkotwar RS. Formulation, development and in vitro characterization of modified release tablets of capecitabine. Drug Dev Ind Pharm. 2020;46(1):20–30.
  • Venugopalarao G, Sreenivas Gowtham M, Sarada NC. Formulation evaluation and stability studies of hydrogel tablets containing cefditoren pivoxil. J Pharm Res. 2013;7(3):230–234.
  • Mujtaba A, Kohli K. In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. Int J Biol Macromol. 2016;89:434–441.
  • Juliano C, Gavini E, Cossu M, et al. Mucoadhesive alginate matrices containing sodium carboxymethyl starch for buccal delivery: in vitro and in vivo studies. J Drug Deliv Sci Technol. 2004;14(2):159–163.
  • Chan LW, Ching AL, Liew CV, et al. Mechanistic study on hydration and drug release behavior of sodium alginate compacts. Drug Dev Ind Pharm. 2007;33(6):667–676.
  • Liew CV, Chan LW, Ching AL, et al. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm. 2006;309(1–2):25–37.
  • Ching AL, Liew CV, Heng PWS, et al. Impact of cross-linker on alginate matrix integrity and drug release. Int J Pharm. 2008;355(1–2):259–268.
  • Ching AL, Liew CV, Chan LW, et al. Modifying matrix micro-environmental pH to achieve sustained drug release from highly laminating alginate matrices. Eur J Pharm Sci. 2008;33(4–5):361–370.
  • Hodsdon AC, Mitchell JR, Davies MC, et al. Structure and behaviour in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices. J Control Release. 1995;33(1):143–152.
  • Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010;74(2):332–339.
  • Mandal S, Basu SK, Sa B. Sustained release of a water-soluble drug from alginate matrix tablets prepared by wet granulation method. AAPS PharmSciTech. 2009;10(4):1348–1356.
  • Miyazaki S, Nakayama A, Oda M, et al. Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate. Int J Pharm. 1995;118(2):257–263.
  • Prajapati ST, Mehta AP, Modhia IP, et al. Formulation and optimisation of raft-forming chewable tablets containing H2 antagonist. Int J Pharm Investig. 2012;2(4):176–182.
  • Shaikh AA, Pawar YD, Kumbhar ST. Effect of chitosan and sodium alginate on mucoadhesion and drug release of itraconazole tablets. Int J Res Pharm Biomed Sci. 2012;3(1):293–297.
  • Giunchedi P, Gavini E, Moretti MDL, et al. Evaluation of alginate compressed matrices as prolonged drug delivery systems. AAPS PharmSciTech. 2000;1(3):31–36.
  • Miyazaki S, Nakayama A, Oda M, et al. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol Pharm Bull. 1994;17(5):745–747.
  • Park HY, Choi CR, Kim JH, et al. Effect of pH on drug release from polysaccharide tablets. Drug Deliv. 1998;5(1):13–18.
  • Güngör S, Yıldız A, Özsoy Y, et al. Investigations on mefenamic acid sustained release tablets with water-insoluble gel. Il Farmaco. 2003;58(5):397–401.
  • Tugcu-Demiroz F, Acarturk F, Takka S, et al. Evaluation of alginate based mesalazine tablets for intestinal drug delivery. Eur J Pharm Biopharm. 2007;67(2):491–497.
  • Jin L, Qi H, Gu X, et al. Effect of sodium alginate type on drug release from chitosan-sodium alginate-based in situ film-forming tablets. AAPS PharmSciTech. 2020;21(55). DOI:10.1208/s12249-019-1549-y.
  • Li L, Wang L, Li J, et al. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release. Int J Pharm. 2014;476(1–2):253–265.
  • El-Kamel A, Sokar M, Naggar V, et al. Chitosan and sodium alginate–based bioadhesive vaginal tablets. AAPS PharmSciTech. 2002;4(4):1–7.
  • Dios P, Nagy S, Pal S, et al. Preformulation studies and optimization of sodium alginate based floating drug delivery system for eradication of Helicobacter pylori. Eur J Pharm Biopharm. 2015;96:196–206.
  • Huang YB, Tsai YH, Lee SH, et al. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm. 2005;289(1–2):87–95.
  • Kanjanabat S, Pongjanyakul T. Preparation and characterization of nicotine–magnesium aluminum silicate complex-loaded sodium alginate matrix tablets for buccal delivery. AAPS PharmSciTech. 2011;12(2):683–692.
  • Ikinci G, Senel S, Wilson CG, et al. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation. Int J Pharm. 2004;277(1–2):173–178.
  • Choi HG, Kim CK. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Release. 2008;68(3):397–404.
  • Abbas G, Hanif M, Khan MA. pH responsive alginate polymeric rafts for controlled drug release by using box behnken response surface design. Des Monomers Polym. 2017;20(1):1–9.
  • Rahim SA, Carter PA, Elkordy AA. Design and evaluation of effervescent floating tablets based on hydroxyethyl cellulose and sodium alginate using pentoxifylline as a model drug. Drug Des Devel Ther. 2015;9:1843–1857.
  • Villena MJ, Lara-Villoslada F, Martinez MA, et al. Development of gastro-resistant tablets for the protection and intestinal delivery of Lactobacillus fermentum CECT 5716. Int J Pharm. 2015;487(1–2):314–319.
  • Kulkarni RV, Baraskar VV, Mallikarjun Setty C, et al. Interpenetrating polymer network matrices of sodium alginate and carrageenan for controlled drug delivery application. Fibers Polym. 2011;12(3):352–358.
  • Efentakis M, Buckton G. The effect of erosion and swelling on the dissolution of theophylline from low and high viscosity sodium alginate matrices. Pharm Dev Technol. 2002;7(1):69–77.
  • Bayomi MA, Al-Suwayeh SA, El-Helw AR. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2001;27(6):499–506.
  • Nokhodchi A, Tailor A. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices. Il Farmaco. 2004;59(12):999–1004.
  • Saeedi M, Akbari J, Enayatifard R, et al. In situ cross-linking of polyanionic polymers to sustain the drug release from theophylline tablets. Iran J Pharm Sci. 2009;8(4):241–249.
  • Li L, Li J, Si S, et al. Effect of formulation variables on in vitro release of a water-soluble drug from chitosan–sodium alginate matrix tablets. Asian J Pharm Sci. 2015;10(4):314–321.
  • Gutsche S, Krause M, Kranz H. Strategies to overcome pH-dependent solubility of weakly basic drugs by using different types of alginates. Drug Dev Ind Pharm. 2008;34(12):1277–1284.
  • Timmins P, Delargy AM, Howard JR. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet. Pharm Dev Technol. 1997;2(1):25–31.
  • Nie S, Wu J, Liu H, et al. Influence of admixed citric acid and physiological variables on the vinpocetine release from sodium alginate compressed matrix tablets. Drug Dev Ind Pharm. 2011;37(8):954–962.
  • Hariharan M, Wheatley TA, Price JC. Controlled-release tablet matrices from carrageenans: compression and dissolution studies. Pharm Dev Technol. 1997;2(4):383–393.
  • Gupta VK, Hariharan M, Wheatley TA, et al. Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors. Eur J Pharm Biopharm. 2001;51(3):241–248.
  • Biswas N, Sahoo RK. Tapioca starch blended alginate mucoadhesive-floating beads for intragastric delivery of metoprolol tartrate. Int J Biol Macromol. 2016;83:61–70.
  • Khlibsuwan R, Tansena W, Pongjanyakul T. Modification of alginate beads using gelatinized and ungelatinized arrowroot (Tacca leontopetaloides L. Kuntze) starch for drug delivery. Int J Biol Macromol. 2018 Oct 15;118(Pt A):683–692.
  • Gürsoy A, Karakus D, Okar I. Polymers for sustained release formulations of dipyridamole-alginate microspheres and tabletted microspheres. J Microencapsul. 1999;16(4):439–452.
  • Gürsoy A, Cevik S. Sustained release properties of alginate microspheres and tabletted microspheres of diclofenac sodium. J Microencapsul. 2000;17(5):565–575.
  • Heng PWS, Chan LW, Liew CV, et al. Effect of tabletting compaction pressure on alginate microspheres. J Microencapsul. 2000 Sep-Oct;17(5):553–564.
  • Pawar SN, Edgar KJ. Alginate derivatization: a review of chemistry, properties and applications. Biomaterials. 2012;33(11):3279–3305.
  • Takeuchi H, Yasuji T, Hino T, et al. Spray-dried composite particles of lactose and sodium alginate for direct tabletting and controlled releasing. Int J Pharm. 1998;174(1–2):91–100.
  • Skják-Bræk G, Smidsrød O, Larsen B. Tailoring of alginates by enzymatic modification in vitro. Int J Biol Macromol. 1986;8(6):330–336.
  • Mørch ÝA, Donati I, Strand BL, et al. Molecular engineering as an approach to design new functional properties of alginate. Biomacromolecules. 2007;8(9):2809–2814.
  • Rosiak P, Latanska I, Paul P, et al. Modification of alginates to modulate their physicochemical properties and obtain biomaterials with different functional properties. Molecules. 2021;26(23):7264.
  • Dey S, Roy S, Hasnain MS, et al. Grafted alginates in drug delivery. In: Nayak AK, Hasnain MS, editors. Alginates in drug delivery. United Kingdom: Acacdemic Press; 2020. p. 71–100.
  • Hasnain MS, Ray P, Nayak AK. Alginate-based interpenetrating polymer networks for sustained drug release. In: Nayak AK, Hasnain MS, editors. Alginates in drug delivery. United Kingdom: Academic Press; 2020. p. 101–128.
  • Kulkarni RV, Baraskar VV, Alange VV, et al. Controlled release of an antihypertensive drug through interpenetrating polymer network hydrogel tablets of tamarind seed polysaccharide and sodium alginate. J Macromol Sci Phys. 2013;52(11):1636–1650.
  • Anwar H, Ahmad M, Minhas MU, et al. Alginate-polyvinyl alcohol based interpenetrating polymer network for prolonged drug therapy, Optimization and in-vitro characterization. Carbohydr Polym. 2017;166:183–194.
  • Zongrui T, Yu C, Wei L. Grafting derivate from alginate. Thakur VK, editor. Biopolymer Grafting: Elsevier; 2018. p. 115–173.
  • Mandal S, Basu SK, Sa B. Ca2+ ion cross-linked interpenetrating network matrix tablets of polyacrylamide-grafted-sodium alginate and sodium alginate for sustained release of diltiazem hydrochloride. Carbohydr Polym. 2010;82(3):867–873.
  • Bamba M, Puisieux F, Marty JP, et al. Release mechanisms in gel forming sustained release preparations. Int J Pharm. 1979;2(5–6):307–315.
  • Conte U, Colombo P, Gazzaniga A, et al. Swelling-activated drug delivery systems. Biomaterials. 1988;9(6):489–493.
  • Baveja SK, Rao KVR, Devi KP. Zero-order release hydrophilic matrix tablets of β-adrenergic blockers. Int J Pharm. 1987;39(1–2):39–45.
  • Maderuelo C, Zarzuelo A, Lanao JM. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release. 2011;154(1):2–19.
  • Omidian H, Park K. Swelling agents and devices in oral drug delivery. J Drug Del Sci Tech. 2008;18(2):83–93.
  • Juszczyk E, Kulinowski P, Baran E, et al. Spatiotemporal analysis of hydration mechanism in sodium alginate matrix tablets. Materials. 2021;14(3):646.
  • Juszczyk E, Kulinowski P, Baran E, et al. Hydration patterns in sodium alginate polymeric matrix tablets-the result of drug substance incorporation. Materials. 2021;14(21):6531.
  • Bruschi ML, editor. Mathematical models of drug release. In: Strategies to modify the drug release from pharmaceutical systems. United Kingdom: Woodhead Publishing; 2015: 63–86.
  • Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48(2–3):139–157.
  • Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50(10):874–875.
  • Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145–1149.
  • Costa P, Manuel J, Lobo S. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–133.
  • Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25–35.
  • Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and non-Fickian release from non swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5(1):23–36.
  • Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm. 1989;57(2):169–172.
  • Fu S, Thacker A, Sperger DM, et al. Rheological evaluation of inter-grade and inter-batch variability of sodium alginate. AAPS PharmSciTech. 2010;11(4):1662–1674.
  • Draget KI, Bræk GS, Smidsrød O. Alginic acid gels: the effect of alginate chemical composition and molecular weight. Carbohydr Polym. 1994;25(1):31–38.
  • Schmid W, Picker-Freyer KM. Tableting and tablet properties of alginates: characterisation and potential for soft tableting. Eur J Pharm Biopharm. 2009;72(1):165–172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.